[FOR RELEASE September 24, 2019 China Biologic Forms Special Committee to Review “Going Private” Proposal BEIJING, China – September 24, 2019 – The Special Committee is composed of Mr. Sean Shao, Dr. Yungang Lu and Mr. Qi Ning, who are independent directors of the Company and are unaffiliated with th]
[FOR RELEASE September 24, 2019 China Biologic Forms Special Committee to Review “Going Private” Proposal BEIJING, China – September 24, 2019 – The Special Committee is composed of Mr. Sean Shao, Dr. Yungang Lu and Mr. Qi Ning, who are independent directors of the Company and are unaffiliated with th]
[Alibaba Group Receives 33% Equity Interest in Ant Financial Hangzhou, China, September 24, 2019 Upon closing of the issuance, the profit-sharing arrangement under which Ant Financial previously paid fees amounting to 37.5% of its pre-tax profits to Alibaba Group was terminated. # # # About Alibaba]
[Alibaba Group Receives 33% Equity Interest in Ant Financial Hangzhou, China, September 24, 2019 Upon closing of the issuance, the profit-sharing arrangement under which Ant Financial previously paid fees amounting to 37.5% of its pre-tax profits to Alibaba Group was terminated. # # # About Alibaba]
[TAOPING INC. (F/K/A CHINA INFORMATION TECHNOLOGY, INC.) UNAUDITED CONSOLIDATED FINANCIAL STATEMENTS FOR THE SIX MONTHS ENDED JUNE 30, 2019 AND 2018 INDEX Contents Page(s) Consolidated Balance Sheets F-2 Consolidated Statements of Operations F-3 Consolidated Statements of Comprehensive Income (Loss) ]
[TAOPING INC. (F/K/A CHINA INFORMATION TECHNOLOGY, INC.) UNAUDITED CONSOLIDATED FINANCIAL STATEMENTS FOR THE SIX MONTHS ENDED JUNE 30, 2019 AND 2018 INDEX Contents Page(s) Consolidated Balance Sheets F-2 Consolidated Statements of Operations F-3 Consolidated Statements of Comprehensive Income (Loss) ]
[September 16, 2019 Dear Shareholders, Our second quarter results demonstrate our ability to run our business profitably in a challenging environment. Results exceeded all expectations due to our outstanding execution. Revenue of $13.6 million was well above guidance; gross margin of 77% significantl]
[September 16, 2019 Dear Shareholders, Our second quarter results demonstrate our ability to run our business profitably in a challenging environment. Results exceeded all expectations due to our outstanding execution. Revenue of $13.6 million was well above guidance; gross margin of 77% significantl]
[2 CHAIRMANS STATEMENT 4 KEY FIGURES 5 BUSINESS OVERVIEW 9 INTERIM CONDENSED CONSOLIDATED STATEMENT OF PROFIT OR LOSS AND OTHER COMPREHENSIVE INCOME 11 INTERIM CONDENSED CONSOLIDATED STATEMENT OF FINANCIAL POSITION 13 INTERIM CONDENSED CONSOLIDATED STATEMENT OF CHANGES IN EQUITY 14 INTERIM CONDENSED]
[2 CHAIRMANS STATEMENT 4 KEY FIGURES 5 BUSINESS OVERVIEW 9 INTERIM CONDENSED CONSOLIDATED STATEMENT OF PROFIT OR LOSS AND OTHER COMPREHENSIVE INCOME 11 INTERIM CONDENSED CONSOLIDATED STATEMENT OF FINANCIAL POSITION 13 INTERIM CONDENSED CONSOLIDATED STATEMENT OF CHANGES IN EQUITY 14 INTERIM CONDENSED]
